Artist® Tablets (Carvedilol) for Hypertensive Patients in Japan: Results of a Drug Use Survey

作者: Yoshihiro Mori , Yasuhiro Nishikawa , Tomoko Iizuka , Natsuko Zenimura , Takuyuki Matsumoto

DOI: 10.2165/11592450-000000000-00000

关键词: DrugHypertension diagnosisTreatment outcomeDrug toxicitySurgeryCreatinine bloodCase report formFamily medicineHypertension complicationsMedicineCarvedilol

摘要: Background: In Japan, when pharmaceutical companies launch a new drug, they are obligated to conduct post-marketing survey evaluate the safety and efficacy of drug in accordance with Good Post-Marketing Surveillance Practice under Article 14-4 (re-examination) Pharmaceutical Affairs Law at contracted medical institutions. We report results long-term special that we conducted as survey.

参考文章(39)
Yasutaka YAMAMOTO, Kazuhiko SONOYAMA, Koichi MATSUBARA, Masako FURUSE, Toru YATSUHASHI, Toshihiro HAMADA, Kazuhide OGINO, Osamu IGAWA, Ichiro HISATOME, Chiaki SHIGEMASA, The status of hypertension management in Japan in 2000. Hypertension Research. ,vol. 25, pp. 717- 725 ,(2002) , 10.1291/HYPRES.25.717
Kazufumi Nakamura, Kengo Kusano, Yoichi Nakamura, Mikio Kakishita, Keiko Ohta, Satoshi Nagase, Mika Yamamoto, Katsumasa Miyaji, Hironori Saito, Hiroshi Morita, Tetsuro Emori, Hiromi Matsubara, Shinya Toyokuni, Tohru Ohe, Carvedilol Decreases Elevated Oxidative Stress in Human Failing Myocardium Circulation. ,vol. 105, pp. 2867- 2871 ,(2002) , 10.1161/01.CIR.0000018605.14470.DD
J Wikstrand, I Warnold, J Tuomilehto, G Olsson, H J Barber, K Eliasson, D Elmfeldt, B Jastrup, N B Karatzas, J Leer, Metoprolol versus thiazide diuretics in hypertension. Morbidity results from the MAPHY Study. Hypertension. ,vol. 17, pp. 579- 588 ,(1991) , 10.1161/01.HYP.17.4.579
Philip A Poole-Wilson, Karl Swedberg, John GF Cleland, Andrea Di Lenarda, Peter Hanrath, Michel Komajda, Jacobus Lubsen, Beatrix Lutiger, Marco Metra, Willem J Remme, Christian Torp-Pedersen, Armin Scherhag, Allan Skene, Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial The Lancet. ,vol. 362, pp. 7- 13 ,(2003) , 10.1016/S0140-6736(03)13800-7
C. Torp-Pedersen, M. Metra, A. Charlesworth, P. Spark, M. A. Lukas, P. A Poole-Wilson, K. Swedberg, J. G F Cleland, A. Di Lenarda, W. J Remme, A. Scherhag, , Effects of metoprolol and carvedilol on pre-existing and new onset diabetes in patients with chronic heart failure: data from the Carvedilol Or Metoprolol European Trial (COMET) Heart. ,vol. 93, pp. 968- 973 ,(2007) , 10.1136/HRT.2006.092379
Aram V Chobanian, George L Bakris, Henry R Black, William C Cushman, Lee A Green, Joseph L Izzo Jr, Daniel W Jones, Barry J Materson, Suzanne Oparil, Jackson T Wright Jr, Edward J Roccella, National High Blood Pressure Education Program Coordinating Committee, None, Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure Hypertension. ,vol. 42, pp. 1206- 1252 ,(2003) , 10.1161/01.HYP.0000107251.49515.C2
Yasuaki Matsuda, Hozuka Akita, Masahiro Terashima, Nobuyuki Shiga, Kenji Kanazawa, Mitsuhiro Yokoyama, Carvedilol improves endothelium-dependent dilatation in patients with coronary artery disease American Heart Journal. ,vol. 140, pp. 753- 759 ,(2000) , 10.1067/MHJ.2000.110093